Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSPC PHARMA

6.150
+0.1001.65%
Volume:183.22M
Turnover:1.13B
Market Cap:71.00B
PE:15.67
High:6.310
Open:6.060
Low:6.060
Close:6.050
Loading ...

CSPC Pharmaceutical Gets FDA Approval for Clinical Trial of Tumor Drug in US

MT Newswires Live
·
16 Jan

CSPC Pharmaceutical - Sys6043 (Antibody-Drug Conjugate) Obtains Clinical Trial Approval in U.S.

THOMSON REUTERS
·
16 Jan

CSPC Pharmaceutical Gets Marketing Nod for Glycemic Control Drug in China

MT Newswires Live
·
13 Jan

CSPC Pharmaceutical - Prusogliptin Tablets Obtains Marketing Approval Granted by Nmpa

THOMSON REUTERS
·
13 Jan

Earnings growth of 1.5% over 5 years hasn't been enough to translate into positive returns for CSPC Pharmaceutical Group (HKG:1093) shareholders

Simply Wall St.
·
11 Jan

CSPC Pharmaceutical Gets China Nod for Clinical Trial of Tumor Drug

MT Newswires Live
·
10 Jan

BRIEF-CSPC Pharmaceutical Says SYS6041 Obtained Clinical Trial Approval

Reuters
·
10 Jan

CSPC Pharmaceutical - Sys6041 Obtains Clinical Trial Approval

THOMSON REUTERS
·
10 Jan

CSPC Pharmaceutical Gets China Nod for Clinical Trial of Tumor Drug

MT Newswires Live
·
07 Jan

BRIEF-CSPC Pharmaceutical Says SYH2059 Tablets Obtains Clinical Trial Approval From NMPA

Reuters
·
07 Jan

BRIEF-CSPC Pharmaceutical Says SYS6045 Obtains Clinical Trial Approval From NMPA

Reuters
·
07 Jan

CSPC Pharmaceutical - Approval Granted by National Medical Products Administration

THOMSON REUTERS
·
07 Jan

CSPC Pharmaceutical - Syh2059 Tablets Obtains Clinical Trial Approval

THOMSON REUTERS
·
07 Jan

CSPC Pharmaceutical's Lung Cancer Drug Receives Breakthrough Therapy Designation in China

MT Newswires Live
·
03 Jan

BRIEF-CSPC Pharmaceutical Says SYS6010 Granted Breakthrough Therapy Designation In China

Reuters
·
02 Jan

Voluntary Announcement - Sys6010 Was Granted Breakthrough Therapy Designation in China

THOMSON REUTERS
·
02 Jan

CSPC Pharmaceutical Secures NMPA Approval for Tumor Drug

MT Newswires Live
·
31 Dec 2024

BRIEF-CSPC Pharmaceutical Says Leuprorelin Extended-Release Injection Obtains Clinical Trial Approval

Reuters
·
30 Dec 2024

Voluntary Announcement - Leuprorelin Extended-Release Injection (Syh9016) Obtains Clinical Trial Approval

THOMSON REUTERS
·
30 Dec 2024

CSPC Pharmaceutical - Clinical Trial Approval Granted by Nmpa of China

THOMSON REUTERS
·
30 Dec 2024